Prolacta Bioscience Adds Joe Fournell And Mitchell Kirk To Management Team

MONROVIA, Calif.--(BUSINESS WIRE)--Prolacta Bioscience, a privately held company that provides specialty formulations of human milk for the immunological and nutritional needs of premature and critically ill infants, announced today the addition of two key members of the management team. Joe Fournell has joined Prolacta as vice president of operations, and Mitchell A. Kirk has joined as vice president of sales and marketing. These two additions will round out the management team, which includes Elena Medo, founder and president; Nathen Fox, chief financial officer; Dr. David Rechtman, chief medical officer; and Dr. Martin Lee, chief scientific officer.